Publicaciones en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (27)

2024

  1. Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients

    Annals of surgical oncology, Vol. 31, Núm. 9, pp. 5615-5630

  2. Impact of Liver Cirrhosis, Severity of Cirrhosis, and Portal Hypertension on the Difficulty and Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies

    Annals of Surgical Oncology, Vol. 31, Núm. 1, pp. 97-114

  3. Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments

    European Journal of Surgical Oncology, Vol. 50, Núm. 1

  4. Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study

    European Journal of Surgical Oncology, Vol. 50, Núm. 6

  5. Propensity Score-Matching Analysis Comparing Robotic Versus Laparoscopic Limited Liver Resections of the Posterosuperior Segments: An International Multicenter Study

    Annals of surgery, Vol. 279, Núm. 2, pp. 297-305

  6. Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome

    JHEP Reports, Vol. 6, Núm. 7

2023

  1. Comparison between the difficulty of laparoscopic limited liver resections of tumors located in segment 7 versus segment 8: An international multicenter propensity-score matched study

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 30, Núm. 2, pp. 177-191

  2. Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study

    Annals of Surgery, Vol. 277, Núm. 4, pp. E839-E848

  3. Impact of Tumor Size on the Difficulty of Laparoscopic Major Hepatectomies: An International Multicenter Study

    Annals of Surgical Oncology, Vol. 30, Núm. 11, pp. 6628-6636

  4. Impact of body mass index on perioperative outcomes of laparoscopic major hepatectomies

    Surgery (United States), Vol. 174, Núm. 2, pp. 259-267

  5. Impact of body mass index on the difficulty and outcomes of laparoscopic left lateral sectionectomy

    European Journal of Surgical Oncology, Vol. 49, Núm. 8, pp. 1466-1473

  6. Impact of liver cirrhosis and portal hypertension on minimally invasive limited liver resection for primary liver malignancies in the posterosuperior segments: An international multicenter study

    European Journal of Surgical Oncology, Vol. 49, Núm. 10

  7. Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study

    European Journal of Surgical Oncology, Vol. 49, Núm. 7, pp. 1209-1216

  8. Impact of tumor size on the difficulty of laparoscopic left lateral sectionectomies

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 30, Núm. 5, pp. 558-569

  9. Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome

    Annals of surgery, Vol. 278, Núm. 5, pp. e1041-e1047

  10. Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomes

    Journal of Hepato-Biliary-Pancreatic Sciences, Vol. 30, Núm. 9, pp. 1098-1110

2022

  1. Utility of the Iwate difficulty scoring system for laparoscopic right posterior sectionectomy: do surgical outcomes differ for tumors in segments VI and VII?

    Surgical Endoscopy, Vol. 36, Núm. 12, pp. 9204-9214

  2. Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery

    BJS Open, Vol. 6, Núm. 1

2021

  1. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  2. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial

    npj Breast Cancer, Vol. 7, Núm. 1